Church & Dwight (NYSE:CHD) recently announced a voluntary recall of several products, including Zicam Cold Remedy Nasal Swabs and Orajel Baby Teething Swabs, due to potential fungal contamination risk ...

Swabs with contamination can be a significant risk to health and safety, including life-threatening blood infections in users with compromised nasal mucosa, Church & Dwight said. The risk is highest ...

Church & Dwight Co., Inc. has called back all lots of Zicam nasal swabs and Orajel baby teething swabs citing potential microbial contamination, according to the U.S. Food and Drug Administration.

Fintel reports that on June 2, 2025, RBC Capital upgraded their outlook for Church & Dwight (NYSE:CHD) from Sector Perform to ...

Key Insights Institutions' substantial holdings in Church & Dwight implies that they have significant influence ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Investing.com -- RBC Capital Markets upgraded Church & Dwight (NYSE: CHD) to Outperform from Sector Perform and raised its ...

Analysts' ratings for Church & Dwight Co CHD over the last quarter vary from bullish to bearish, as provided by 13 analysts. The following table encapsulates their recent ratings, offering a ...

What Happened: Hooker, EVP at Church & Dwight Co, made a strategic move by exercising stock options for 3,000 shares of CHD as detailed in a Form 4 filing on Friday with the U.S. Securities and ...

On Tuesday, 03 June 2025, Church & Dwight (NYSE:CHD) presented its strategic initiatives and financial outlook at the 2025 dbAccess Global Consumer Conference. The company emphasized its ...

Church & Dwight Co., Inc. (NYSE: CHD) announced today that President and Chief Executive Officer Rick Dierker, Chief Financial Officer Lee McChesney, and Executive Vice President of International ...